MedTrace Logo

Circulating Endothelial Progenitor Cells and Aortic Aneurysm

NCT01918982 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-08-08

No results posted yet for this study

Summary

We aimed to see if aortic aneurysms could be followed-up by circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- blood level.

Conditions

  • - Aortic Aneurysm

Sponsors & Collaborators

  • Hopital Jean Minjoz

    lead OTHER

Principal Investigators

  • Sidney Chocron, MD, PhD · Université de Franche-comté. France

  • Andrea Perrotti, MD · Université de Franche-Comté. France

  • Simon Rinckenbach, MD, PhD · Université de Franche-Comté. France

  • Siamak Davani, MD, PhD · Université de Franche-Comté. France

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-02-29
Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01918982 on ClinicalTrials.gov